https://insisvaccine.org/news daily 0.75 2022-02-08 https://insisvaccine.org/publications daily 0.75 2025-11-05 https://insisvaccine.org/publications/h08v1oixntb8jpurffa1e1d1r3iiqe monthly 0.5 2025-11-05 https://insisvaccine.org/publications/biomarkers-of-vaccine-safety-and-efficacy-in-vulnerable-populations-lessons-from-the-fourth-international-precision-vaccines-conference monthly 0.5 2024-12-18 https://insisvaccine.org/publications/report-of-a-speac-webinar-22-september-2023-sensorineural-hearing-loss-lassa-virus-disease-and-vaccines monthly 0.5 2024-12-06 https://insisvaccine.org/publications/funding-postauthorization-vaccine-safety-science monthly 0.5 2024-12-10 https://insisvaccine.org/publications/cid-ciac407 monthly 0.5 2024-12-18 https://insisvaccine.org/publications/category/2022 monthly 0.5 https://insisvaccine.org/publications/tag/systems+biology monthly 0.5 https://insisvaccine.org/publications/tag/Clinical+Infectious+Diseases monthly 0.5 https://insisvaccine.org/publications/tag/SARS-CoV-2 monthly 0.5 https://insisvaccine.org/publications/tag/Adverse+Events+Following+Immunization monthly 0.5 https://insisvaccine.org/publications/tag/Vaccine+Safety monthly 0.5 https://insisvaccine.org/publications/tag/Funding monthly 0.5 https://insisvaccine.org/publications/tag/AEFI monthly 0.5 https://insisvaccine.org/publications/tag/geonomics monthly 0.5 https://insisvaccine.org/publications/tag/vaccination monthly 0.5 https://insisvaccine.org/news-2 daily 0.75 2024-12-10 https://insisvaccine.org/news-2/report-of-a-speac-webinar-22-september-2023-sensorineural-hearing-loss-lassa-virus-disease-and-vaccines monthly 0.5 2024-12-05 https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/1733357586025-PO54F76NV3LG6VUR2TVS/unsplash-image-MNmLTgotAVA.jpg News - Exploring the Intersection of Sensorineural Hearing Loss, Lassa Virus, and Vaccine Safety: Insights from the SPEAC Webinar - Ensuring Safety in LASV Vaccine Trials Although early clinical trials of LASV vaccines have not reported SNHL as an adverse event, the high prevalence of hearing loss in LASV survivors necessitates proactive safety measures in vaccine development. Baseline and follow-up hearing assessments are crucial for identifying potential vaccine-related ototoxicity. Advances in portable audiometric technology can facilitate these evaluations, particularly in resource-limited settings. https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/1733356310243-EU98B866V6SITGWLXJNP/unsplash-image-CG6Gd__QIOY.jpg News - Exploring the Intersection of Sensorineural Hearing Loss, Lassa Virus, and Vaccine Safety: Insights from the SPEAC Webinar - The Burden of Sensorineural Hearing Loss in Lassa Fever Survivors SNHL associated with LF often manifests during recovery and can range from mild to profound. While some cases are transient, most are permanent. Research highlights the profound impact of SNHL on quality of life, especially in regions like West Africa, where access to hearing interventions is limited. The condition’s pathophysiology remains unclear, but immune-mediated damage, rather than direct viral effects, appears to be a key factor. https://insisvaccine.org/news-2/insis-featured-on-ici-radio-canada-advancing-vaccine-safety-research monthly 0.5 2024-12-07 https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/850b4a3a-ddea-4326-b997-8e0df94bc280/29309-101240.jpg News - INSIS Featured on ICI Radio-Canada: Advancing Vaccine Safety Research - Tackling Very Rare Vaccine Side Effects INSIS, a global consortium based at the University of Alberta, is investigating the rare adverse effects of COVID-19 vaccines. With support from the Coalition for Epidemic Preparedness Innovations (CEPI) and $15.3 million in funding, INSIS aims to uncover how vaccines might trigger these side effects and to develop solutions that pave the way for safer vaccines in the future. A “very rare” adverse reaction affects less than 0.001% of the population. These events are often detected only after vaccines are distributed widely, as clinical trials cannot capture the full diversity of health conditions and genetic backgrounds present in large populations. INSIS is leveraging international data to compare cases of these side effects, offering insights to improve vaccine design and safety. https://insisvaccine.org/news-2/tag/INSIS monthly 0.5 https://insisvaccine.org/news-2/tag/Lassa+virus+immunity monthly 0.5 https://insisvaccine.org/news-2/tag/AESI monthly 0.5 https://insisvaccine.org/news-2/tag/lassa+virus monthly 0.5 https://insisvaccine.org/news-2/tag/CBC monthly 0.5 https://insisvaccine.org/news-2/tag/Lassa+virus+vaccination monthly 0.5 https://insisvaccine.org/news-2/tag/AEFI monthly 0.5 https://insisvaccine.org/news-2/tag/hearing+loss monthly 0.5 https://insisvaccine.org/news-2/tag/SPEAC monthly 0.5 https://insisvaccine.org/news-2/tag/ICI monthly 0.5 https://insisvaccine.org/home daily 1.0 2025-01-02 https://insisvaccine.org/partners daily 0.75 2023-07-26 https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/410c6574-c176-432f-8fff-2d146d5a870b/SS_AusVaxSafety.jpg https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/fbed4fc8-354b-40e9-aa5d-b80e7485878f/SS_CCFV.jpg https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/8c12a3e9-f210-48c7-858f-b290a3c73b01/logo-opbg_ufficiale_intranet.jpg https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/47b7eb75-e6c1-497d-9393-07a49c245a18/SS_VUMC.jpg https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/1643138742289-25BA9NLYSI3XHHLDH9G8/SS_MayoClinic.jpg https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/12f2e493-8594-48b3-95a3-4960c85b0e6c/SS_Dalhousie.jpg https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/6a76940a-4516-40df-8294-f73813c49a9d/Picture1.png https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/1643135415926-PI2I7I037KA7X0ODPBEC/SS_CPNDS.jpg https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/c5652377-b7d3-4ad6-a806-83d9d6e9b9b9/SS_GVDN.jpg https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/634ed249-cbd4-4da0-a445-a2336039f028/SS_PVP.jpg https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/2ad897a5-6f1c-4a30-b9d0-3d822b7e7396/SS_ALIVE.png https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/1643055919494-V6DJ3Y2ZRDGZ7ONBYS86/SS_CIRN.jpg Partners https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/1643055946789-SN6YVC4ZEBCN5LWDE47F/SS_Brighton.jpg Partners https://insisvaccine.org/contact daily 0.75 2023-08-17 https://insisvaccine.org/about daily 0.75 2022-02-17 https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/a438f1ae-2e1d-432e-99b9-592c4138e01b/doctor-prepares-form-for-covid-vaccine-2022-02-01-19-38-15-utc.jpg About - No one country can do it alone. INSIS provides a platform for experts worldwide to collaborate and provide unprecedented insight into rare adverse events following COVID-19 vaccination. https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1618497259178-6XJGK9GR6YAVBQL5L519/20140301_Trade-151_012-2.jpg About https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1607694583486-2PQT0LQ193RL7MCB6DX4/20140228_Trade+151_0046.jpg About https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1607694644871-IC85FNH781UNZSZEGHDR/Aro+Ha_0428.jpg About https://insisvaccine.org/leadership daily 0.75 2025-05-28 https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/db7aef87-1755-418e-8451-9725608b8573/KARINA+TOP+2025_cropped.jpg Leadership - Dr. Karina Top Principal Investigator https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/0079f401-3dbc-4796-a6a3-68d2bf771b9e/RobertChen4361-683x1024.jpg Leadership - Dr. Robert Chen Principal Investigator https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1618497259178-6XJGK9GR6YAVBQL5L519/20140301_Trade-151_012-2.jpg Leadership https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1607694644871-IC85FNH781UNZSZEGHDR/Aro+Ha_0428.jpg Leadership https://images.squarespace-cdn.com/content/v1/61ddaef9b8170b5bc9d41bd9/ab0365f2-2465-4f4d-ab9a-5555cc9dbcd8/INSISGradient-01.png Leadership